Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L V Favreau

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|October 10, 1982
Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidaseJ J Castellot, L V Favreau, M J Karnovsky, et al.
The Journal of Biological Chemistry|December 25, 1989
Rat liver NAD(P)H: Quinone reductase. Regulation of quinone reductase gene expression by planar aromatic compounds and determination of the exon structure of the quinone reductase structural geneR M Bayney, M R Morton, L V Favreau, et al.
Archives of Biochemistry and Biophysics|November 1, 1988
Further characterization of RLM2 and comparison with a related form of cytochrome P-450, RLM2bK E Thummel, L V Favreau, J E Mole, et al.
The Journal of Biological Chemistry|January 10, 1982
Heparin with two binding sites for antithrombin or platelet factor 4R E Jordan, L V Favreau, E H Braswell, et al.
Archives of Biochemistry and Biophysics|February 15, 1988
Regioselective hydroxylation of prostaglandins by constitutive forms of cytochrome P-450 from rat liver: formation of a novel metabolite by a female-specific P-450D Kupfer, I Jansson, L V Favreau, et al.
Archives of Toxicology|January 1, 1987
Fingerprinting rat liver microsomal cytochromes P-450 as a means of delineating sexually distinctive formsJ B Schenkman, L V Favreau, J Mole, et al.
Archives of Biochemistry and Biophysics|February 1, 1987
Biochemical and immunological identity of the hepatic peroxisomal and microsomal trans-2-enoyl CoA hydratase bifunctional proteinL Cook, D Ghesquier, M N Nagi, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
Differences in the spectral interactions between NADPH-cytochrome P-450 reductase and a series of cytochrome P-450 enzymesP P Tamburini, I Jansson, L V Favreau, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
Inhibition of CYP3A4 in a rapid microtiter plate assay using recombinant enzyme and in human liver microsomes using conventional substratesA A Nomeir, C Ruegg, M Shoemaker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2001
Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidineJ R Palamanda, C N Casciano, L A Norton, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|October 10, 1982
Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidaseJ J Castellot, L V Favreau, M J Karnovsky, et al.
The Journal of Biological Chemistry|December 25, 1989
Rat liver NAD(P)H: Quinone reductase. Regulation of quinone reductase gene expression by planar aromatic compounds and determination of the exon structure of the quinone reductase structural geneR M Bayney, M R Morton, L V Favreau, et al.
Archives of Biochemistry and Biophysics|November 1, 1988
Further characterization of RLM2 and comparison with a related form of cytochrome P-450, RLM2bK E Thummel, L V Favreau, J E Mole, et al.
The Journal of Biological Chemistry|January 10, 1982
Heparin with two binding sites for antithrombin or platelet factor 4R E Jordan, L V Favreau, E H Braswell, et al.
Archives of Biochemistry and Biophysics|February 15, 1988
Regioselective hydroxylation of prostaglandins by constitutive forms of cytochrome P-450 from rat liver: formation of a novel metabolite by a female-specific P-450D Kupfer, I Jansson, L V Favreau, et al.
Archives of Toxicology|January 1, 1987
Fingerprinting rat liver microsomal cytochromes P-450 as a means of delineating sexually distinctive formsJ B Schenkman, L V Favreau, J Mole, et al.
Archives of Biochemistry and Biophysics|February 1, 1987
Biochemical and immunological identity of the hepatic peroxisomal and microsomal trans-2-enoyl CoA hydratase bifunctional proteinL Cook, D Ghesquier, M N Nagi, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
Differences in the spectral interactions between NADPH-cytochrome P-450 reductase and a series of cytochrome P-450 enzymesP P Tamburini, I Jansson, L V Favreau, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
Inhibition of CYP3A4 in a rapid microtiter plate assay using recombinant enzyme and in human liver microsomes using conventional substratesA A Nomeir, C Ruegg, M Shoemaker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2001
Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidineJ R Palamanda, C N Casciano, L A Norton, et al.
Pageof 2